Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice
Clinical trial NCT02555839 · COMPLETED
Trial details
- NCT number
- NCT02555839
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-20
- Primary completion
- 2023-06-30
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.